PARK MEDI WORLD LIMITED (PARKHOSPS) financials

PARK MEDI WORLD LIMITED (PARKHOSPS) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Park Medi World engaged in the business of, inter alia, establishing, maintaining and running hospitals, nursing homes, clinics, dispensaries, maternity homes, child welfare, family planning etc.(Source : 202503 Annual Report Page No:320)

Market Cap: ₹10,181Cr.
Current Price: ₹236
Stock P/E: 310
ROE: 7.52%
ROCE: 10.0%
Book Value: ₹19.9
Dividend Yield: 0.00%
52W High / Low: ₹305/138

In Jun 2026, PARK MEDI WORLD LIMITED (PARKHOSPS) reported sales ₹33.53 Cr and net profit ₹1.08 Cr.

Annual TTM: sales ₹140 Cr, net profit ₹33 Cr.

Shareholding: Promoters 82.89% (Jun 2026), FIIs 0.82% (Jun 2026), DIIs 8.95% (Jun 2026), Government 0.00% (Jun 2026), Public 7.33% (Jun 2026).

PARKHOSPS quarterly results (₹ Cr.)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	22.76	23.26	22.97	32.69	45.87	27.43	33.53
Expenses	18.09	15.37	12.62	17.39	27.85	22.66	32.25
Operating Profit	4.67	7.89	10.35	15.30	18.02	4.77	1.28
OPM %	20.52%	33.92%	45.06%	46.80%	39.28%	17.39%	3.82%
Other Income	0.31	0.98	0.20	0.28	5.52	8.27	4.67
Interest	3.14	3.17	3.30	3.43	3.61	2.42	0.86
Depreciation	1.30	1.33	1.16	1.16	1.18	1.01	3.38
Profit before tax	0.54	4.37	6.09	10.99	18.75	9.61	1.71
Tax %	66.67%	20.37%	19.70%	22.11%	22.40%	10.51%	36.26%
Net Profit	0.18	3.48	4.90	8.55	14.56	8.61	1.08
EPS in Rs	0.00	0.09	0.13	0.22	0.34	0.20	0.03
Raw PDF	—	—	—	—	—	—	—

PARKHOSPS profit and loss (₹ Cr.)
Category	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	110	102	90	92	129	140
Expenses	89	79	64	67	77	100
Operating Profit	21	24	26	24	52	39
OPM %	19%	23%	29%	26%	41%	28%
Other Income	15	5	5	2	10	19
Interest	20	13	14	12	13	10
Depreciation	3	5	5	5	5	7
Profit before tax	13	10	13	9	45	41
Tax %	34%	32%	40%	19%	19%	—
Net Profit	8	7	8	7	37	33
EPS in Rs	0.22	0.18	0.20	0.19	0.85	0.79
Dividend Payout %	0%	0%	0%	0%	0%	—

PARKHOSPS balance sheet (₹ Cr.)
Category	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	77	77	77	77	86
Reserves	21	24	30	37	774
Borrowings	99	114	125	168	19
Other Liabilities	32	60	45	37	38
Total Liabilities	229	275	277	320	917
Fixed Assets	20	34	73	75	71
CWIP	8	5	13	37	106
Investments	102	148	149	149	382
Other Assets	98	88	42	59	358
Total Assets	229	275	277	320	917

PARKHOSPS cash flows (₹ Cr.)
Category	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	-10	45	48	5	17
Cash from Investing Activity	19	-39	-51	-28	-481
Cash from Financing Activity	-9	-1	-5	25	547
Net Cash Flow	-0	5	-8	1	84
Free Cash Flow	-39	46	-3	-25	-49
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	-27%	228%	199%	29%	50%

PARKHOSPS shareholding pattern (%)
Category	Dec 2025	Mar 2026	Jun 2026
Promoters	82.89%	82.89%	82.89%
FIIs	1.28%	0.86%	0.82%
DIIs	8.58%	8.95%	8.95%
Government	0.20%	0.30%	0.00%
Public	7.06%	6.98%	7.33%
No. of Shareholders	1,14,600	50,863	52,428

PARKHOSPS key ratios
Category	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	147	127	90	133	110
Inventory Days	3	2	2	—	—
Days Payable	114	196	349	—	—
Cash Conversion Cycle	36	-68	-257	133	110
Working Capital Days	96	-213	-369	-386	596
ROCE %	—	12%	12%	8%	10%

PARKHOSPSUpdated 19 Oct 2026, 3:30

Park Medi World Limited

PARKHOSPSUpdated 19 Oct 2026, 3:30

Market Cap

₹10,181Cr.

Current Price

₹236

High / Low

₹305/138

Stock P/E

310

ROE7.52%

ROCE10.0%

Book Value₹19.9

Face Value₹2.00

Dividend Yield0.00%

About

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Dec 2024	22.76	3.14	18.09	0.31	1.3	0.54	66.67	0.18	0
Mar 2025	23.26	3.17	15.37	0.98	1.33	4.37	20.37	3.48	0.09
Jun 2025	22.97	3.3	12.62	0.2	1.16	6.09	19.7	4.9	0.13
Sep 2025	32.69	3.43	17.39	0.28	1.16	10.99	22.11	8.55	0.22
Dec 2025	45.87	3.61	27.85	5.52	1.18	18.75	22.4	14.56	0.34
Mar 2026	27.43	2.42	22.66	8.27	1.01	9.61	10.51	8.61	0.2
Jun 2026	33.53	0.86	32.25	4.67	3.38	1.71	36.26	1.08	0.03

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2022	110	20	89	15	3	13	34	8	0.22
Mar 2023	102	13	79	5	5	10	32	7	0.18
Mar 2024	90	14	64	5	5	13	40	8	0.2
Mar 2025	92	12	67	2	5	9	19	7	0.19
Mar 2026	129	13	77	10	5	45	19	37	0.85
TTM	140	10	100	19	7	41	—	33	0.79

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	82.89%
FIIs	0.82%
DIIs	8.95%
Public	7.33%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2025	82.89%	1.28%	8.58%	0.2%	7.06%
Mar 2026	82.89%	0.86%	8.95%	0.3%	6.98%
Jun 2026	82.89%	0.82%	8.95%	0%	7.33%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2022	77	21	99	32	229	20	8	102	98	229
Mar 2023	77	24	114	60	275	34	5	148	88	275
Mar 2024	77	30	125	45	277	73	13	149	42	277
Mar 2025	77	37	168	37	320	75	37	149	59	320
Mar 2026	86	774	19	38	917	71	106	382	358	917

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2022	-10	19	-9	0
Mar 2023	45	-39	-1	5
Mar 2024	48	-51	-5	-8
Mar 2025	5	-28	25	1
Mar 2026	17	-481	547	84

Key ratios

Historical financial ratios

Category	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	147	127	90	133	110
Inventory Days	3	2	2	—	—
Days Payable	114	196	349	—	—
Cash Conversion Cycle	36	-68	-257	133	110
Working Capital Days	96	-213	-369	-386	596
ROCE %	—	12%	12%	8%	10%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of PARK MEDI WORLD LIMITED (PARKHOSPS)?

The reported market capitalisation for PARK MEDI WORLD LIMITED (PARKHOSPS) is ₹10,181Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of PARKHOSPS?

The current price shown for PARK MEDI WORLD LIMITED (PARKHOSPS) on Fincrux is ₹236 with a 52-week high/low of ₹305/138.

What is the P/E ratio of PARK MEDI WORLD LIMITED (PARKHOSPS)?

The stock P/E for PARK MEDI WORLD LIMITED (PARKHOSPS) is 310 on Fincrux, with ROE at 7.52% and ROCE at 10.0%.

What were PARKHOSPS latest quarterly results?

For Jun 2026, PARK MEDI WORLD LIMITED (PARKHOSPS) reported sales ₹33.53 Cr and net profit ₹1.08 Cr (figures in ₹ crore unless noted).

What are PARKHOSPS annual sales and net profit?

For TTM, PARK MEDI WORLD LIMITED (PARKHOSPS) shows sales of ₹140 Cr and net profit of ₹33 Cr on the Fincrux profit & loss statement.

Who owns PARK MEDI WORLD LIMITED (PARKHOSPS)?

Latest shareholding for PARK MEDI WORLD LIMITED (PARKHOSPS) on Fincrux: Promoters 82.89% (Jun 2026), FIIs 0.82% (Jun 2026), DIIs 8.95% (Jun 2026), Government 0.00% (Jun 2026), Public 7.33% (Jun 2026).

Where can I find PARK MEDI WORLD LIMITED (PARKHOSPS) financials?

PARK MEDI WORLD LIMITED (PARKHOSPS) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show PARKHOSPS balance sheet and cash flow?

Yes. The PARK MEDI WORLD LIMITED (PARKHOSPS) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 3:30